KRAS as a predictor of poor prognosis and benefit from...

Molecular Oncology 2015 / 08 Vol. 9; Iss. 7

KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer

Deng, Yanhong, Wang, Li, Tan, Shuyun, Kim, George P., Dou, Ruoxu, Chen, Dianke, Cai, Yue, Fu, Xinhui, Wang, Lei, Zhu, Jun, Wang, Jianping
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2015.03.006
Date:
August, 2015
File:
PDF, 570 KB
english, 2015
Conversion to is in progress
Conversion to is failed